ECMO Machine Market worth $673 Million by 2026

The global ECMO machine market is expected to reach $673 million by 2026, growing at a compound annual growth rate (CAGR) of 4.9%.

According to research report the ECMO Machine Market was valued at $531 million in 2021 and is expected to reach $673 million by 2026, growing at a compound annual growth rate (CAGR) of 4.9%. ECMO machines provide prolonged cardiac and respiratory support to critically ill patients, playing a crucial role in modern intensive care units.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255167654

Market Drivers

Expanding Geriatric Population

The growing elderly population is a significant driver for the ECMO machine market. As people age, the prevalence of chronic respiratory and cardiovascular diseases increases, leading to a higher demand for advanced medical interventions like ECMO.

Increasing Prevalence of Chronic Diseases

The global rise in chronic respiratory and cardiovascular diseases fuels the demand for ECMO machines. Chronic obstructive pulmonary disease (COPD), the third leading cause of death worldwide, highlights the urgent need for effective respiratory support systems. Additionally, ECMO machines are becoming increasingly vital in lung transplantation procedures, particularly for patients with severe acute respiratory distress syndrome (ARDS).

Technological Advancements

Technological improvements have significantly boosted the adoption of ECMO machines. Modern ECMO systems allow for faster and more accurate diagnosis and treatment compared to older equipment. However, the high cost of ECMO therapies remains a barrier to widespread adoption, particularly in developing countries with limited healthcare budgets and infrastructure.

Market Challenges

High Costs

The high cost of ECMO equipment, extended hospital stays, and the necessity for specialized medical teams make ECMO therapy unaffordable for many patients. This financial barrier is exacerbated by declining insurance reimbursements, posing an additional challenge for market growth.

Infrastructure and Workforce Limitations

The lack of adequate healthcare infrastructure and trained ECMO specialists in many regions hampers the wider adoption of ECMO therapies. Developing training programs to increase the number of qualified ECMO specialists could help address this issue.

Opportunities for Growth

Improved Patient Survival Rates

Increasing ECMO machine usage has led to higher patient survival rates in critical cardiac and respiratory cases, presenting a key growth avenue for ECMO machine manufacturers and medical providers.

Development of Portable ECMO Devices

The development of portable and easier-to-operate ECMO devices offers significant growth opportunities. Portable ECMO machines are expected to dominate in the coming years due to their transportability and mobility for critically ill patients.

Market Segmentation

By Application

• Respiratory Care: The respiratory care segment accounted for the largest share of the global ECMO machine market in 2020. The rising prevalence of pulmonary diseases drives demand for respiratory ECMO therapies.
• Modality: The arterio-venous segment dominated the market due to its dynamic range and diagnostic value.

By Patient Type

• Adults: ECMO machine usage for adults contributed the greatest market share, improving outcomes for older patients with heart and lung failure.

By Component

• Controllers: ECMO machine controllers accounted for the largest share due to their affordability compared to other components like pumps and oxygenators.

Geographical Insights

• Asia-Pacific: The Asia-Pacific region is poised to register the fastest growth rate in the global ECMO machine market through 2026. Factors driving this growth include the expanding elderly population, increasing disposable incomes, high disease burden, and supportive government policies in countries like Japan, China, and India.

Key Market Players

Leading players in the global ECMO machine market include:

• Getinge Group
• Medtronic
• Fresenius Medical Care
• Microport
• Terumo Cardiovascular Systems Corporation

These companies are focusing on new product development and strategic partnerships to enhance their market presence. Recent key developments include regulatory approvals for new ECMO devices in the U.S. and China.

Request Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=255167654

Conclusion

The ECMO machine market is set for steady growth, driven by the rising prevalence of chronic cardiovascular and respiratory illnesses and ongoing technological advancements. However, high costs, reimbursement issues, and infrastructure limitations pose challenges. To tap into this market’s strong growth potential, companies are investing in research and development and expanding their geographic reach.

Related News & Articles:

https://www.prnewswire.com/news-releases/extracorporeal-membrane-oxygenation-machine-market-worth-673-million-by-2026–exclusive-report-by-marketsandmarkets-301432318.html

https://www.whatech.com/og/markets-research/medical/693810-ecmo-machine-market-growing-at-a-cagr-of-4-3-according-to-a-new-research-report

https://www.linkedin.com/pulse/ecmo-machine-market-size-share-trends-future-growth-p4ftf

https://www.linkedin.com/pulse/ecmo-machine-market-size-share-regional-insights-mayuri-lamba-nsqxf/

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]